Our Reference: L/M (12) in ImmD CIC/6-5/10 (R)
Dear Surabhi Chopra,
I refer to your request for access to information on 15 September 2021 and
our...
Our Reference: L/M (526) in ImmD DR/6-5/10/R
Dear Raquel Amador,
I refer to your request for access to information on 15.09.2021 and our
interim re...
Our Reference: L/M (525) in ImmD DR/6-5/10/R
Dear Surabhi Chopra,
I refer to your request for access to information on 15.09.2021 and our
interim r...
Our Reference: L/M (527) in ImmD DR/6-5/10/R
Dear Surabhi Chopra,
I refer to your request for access to information on 15.09.2021 and our
interim r...
Our Reference: L/M (4) in ImmD CIC/6-5/10 (R)
Dear RAQUEL AMADOR,
I refer to your request for access to information on 6 October 2021 and
our previ...
Our Reference: L/M (6) in ImmD CIC/6-5/10 (R) Pt.2
Dear Surabhi Chopra,
I refer to your request for access to information on 12 October 2021 and
ou...
Our Reference: L/M (8) in ImmD CIC/6-5/10 (R) Pt.2
Dear Surabhi Chopra,
I refer to your request for access to information on 12 October 2021 and
ou...
Our Reference: L/M (536) in ImmD DR/6-5/10/R
Dear Surabhi Chopra,
I refer to your request for access to information on 12.10.2021 and our
interim...
Our Reference: L/M (13) in ImmD CIC/6-5/10 (R) Pt.2
Dear Surabhi Chopra,
I refer to your request for access to information on 20 October 2021 and
o...
Our Reference: L/M (540) in ImmD DR/6-5/10/R
Dear Surabhi Chopra,
I refer to your request for access to information on 20 October 2021 and
our int...
Can you please advise the following:
-Number of patients that have been prescribed Remdesivir from 2015 -2021 (to date)
-The condition/ disease the...
Can you please advise the following:
-Number of patients that have been prescribed Remdesivir from 2015 -2021 (to date)
-The condition/ disease the...
Our Reference: L/M (541) in ImmD DR/6-5/10/R
Dear Surabhi Chopra,
I refer to your request for access to information on 20 October 2021 and
our inte...
Many thanks for your reply on this important topic, I really appreciate the effort! I have some followup questions since not all of the information wa...
Can you please advise the following:
-Number of patients that have been prescribed Remdesivir from 2015 -2022
(to date)
-The condition/ disease t...
Our Reference: L/M (590) in ImmD DR/6-5/10/R
Dear H.Y. FUNG,
I hereby provide you with the following information.
(1) The number of cases of physi...
I am writing to request the marker’s report of all DSE Category A subjects from 2015 onwards.
Yours faithfully,
Kennis Cheung
Ms Dotto,
I refer to your application under the Code on Access to
Information dated 2023-08-03 and the information is provided below:
2....
Our ref.: L/M (133) in ImmD RALS1/6-20/3/C
Dear Jade Anderson,
We refer to your application for access to information of 26 February 2024...
Our ref. : L/M in ImmD RALOS/6-20/3/C
Dear Mr Shaffer,
Thank you for your email enquiry of 6 May 2018 enquiring about the number
of non-refoul...
本處檔號: L/M in ImmD RALOS/6-20/3/C
Dear Ms Li,
Thank you for your email enquiry dated 15 June 2017. Further to our
interim replies dated 24...
傳真 : 2882 8149
電話 : 2629 0428
本函檔號 : L/M (5) to OMB/G/16/03 III
主旨 : 索取資料要求 – 有關「政府推行《公開資料守則》的成效」的主動
調查報告的中文版本 (OMB/DI/189)...
傳真 : 2882 8149
電話 : 2629 0428
本函檔號 : L/M (4b) to OMB/G/16/03 III
主旨 : 索取資料要求 – 有關「綜合電話查詢中心」運作的主動調查報告
stranbusel君:
二O一五年十一月十...
We are a group of students from Hong Kong Baptist University and working on a project about Prisoners’ Welfare in Hong Kong. We are writing to seek inf...
傳真 : 2882 8149
電話 : 2629 0428
本函檔號 : L/M (4c) to OMB/G/16/03 III
主旨 : 索取資料要求 – 有關公開考試試卷編製的主動調查報告
stranbusel君:
二O一五年十一月十六日的電...